Virtual Reality for Pain Control in US-Guided Obstetric Needle Procedures
1 other identifier
interventional
50
1 country
1
Brief Summary
This is a single-site randomized controlled pilot study at Mount Sinai Hospital evaluating the effect of virtual reality on procedural pain and anxiety in obstetric patients undergoing ultrasound-guided needle procedures. Patients will be randomized to receive either VR or standard care during the procedure and complete validated questionnaires assessing pain, anxiety, intervention acceptability, and satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2025
CompletedFirst Submitted
Initial submission to the registry
July 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 30, 2027
July 30, 2025
July 1, 2025
1.7 years
July 23, 2025
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Short-form McGill Pain Questionnaire
The Short-form McGill Pain Questionnaire (SF-MPQ) is used to assess procedural pain and its qualities, such as 'sharpness.' The total score ranges from 0 to 45, with higher scores indicating more pain. It includes subscales for Sensory (0-33), Affective (0-12), a Visual Analogue Scale (0-10), and Present Pain Intensity (0-5).
Immediately post-procedure
Secondary Outcomes (3)
Acceptability of Intervention Measure (AIM)
Immediately post-procedure (procedure lasts approximately 20 minutes)
State-Trait Anxiety Inventory (STAI)
Immediately Pre-procedure and immediately post-procedure (procedure lasts approximately 20 minutes)
Visual Analog Scale for Satisfaction
Immediately post-procedure (procedure lasts approximately 20 minutes)
Study Arms (2)
Patients without Virtual Reality (VR)
ACTIVE COMPARATORStandard of care procedure without virtual reality.
Patients with Virtual Reality
EXPERIMENTALUltrasound-guided (US-Guided) procedure with virtual reality. Participants will wear a Meta Quest 2 virtual reality headset during their ultrasound-guided needle procedure.
Interventions
Meta Quest 2 virtual reality headset. The VR experience includes an interactive, immersive environment with classical music and wrist-controlled movement to match floating visual cues to a beat. The experience is designed to be soothing and require minimal movement.
Ultrasound-guided (US-Guided) procedure
Eligibility Criteria
You may qualify if:
- Age ≥18
- English-speaking
- Undergoing ultrasound-guided needle procedure at Mount Sinai
You may not qualify if:
- History of seizures
- Severe motion sickness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai Obstetrics and Gynecology
New York, New York, 10029, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Katz, MD
Icahn School of Medicine at Mount Sinai
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Vice Chair of Education for the Department of Anesthesiology, Pain, & Perioperative Medicine
Study Record Dates
First Submitted
July 23, 2025
First Posted
July 30, 2025
Study Start
July 2, 2025
Primary Completion (Estimated)
March 30, 2027
Study Completion (Estimated)
March 30, 2027
Last Updated
July 30, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
This is a single-site, small-scale pilot study that does not include the collection of biospecimens or long-term follow-up data. The data collected are limited to de-identified questionnaire responses.